MAPK
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 52109 | Trametinib (GSK1120212) | 871700-17-3 | 98% | -cas-871700-17-3.png) |
| Trametinib (GSK1120212) is a highly specific and potentMEK1/2inhibitor withIC50of 0.9 | ||||
| 20432 | GDC-0134 | 1637394-01-4 | ≧98.0% | -5-[2-(3,3-difluoro-1-pyrrolidinyl)-6-(1S,4S)-2-oxa-5-azabicyclo[2.2.1]hept-5-yl-4-pyrimidinyl]-_1637394-01-4.png) |
| GDC-0134 is a MAP3K12 (DLK) Inhibitor. | ||||
| 24012 | Zunsemetinib | 1640282-42-3 | ≧98.0% |  |
| Zunsemetinib is an investigational oral mitogen-activated protein kinase-activated pr | ||||
| 25046 | BI-847325 | 2128698-24-6 | ≧98.0% |  |
| BI-847325 is a novel, ATP-competitive, orally available inhibitor of Aurora kinases a | ||||